서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 8 of 8

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2004-02	Transforming growth factor-β1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells Kim, Sang Gyun; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Kim, Noe Kyeong; Hong, Seung Hwan; Bang, Yung-Jue Molecular Biology of the Cell, Vol.15 No.2, pp.420-434	DOI
2005-08	Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor Im, Seock-Ah; Kim, Sung-Bae; Lee, Moon Hee; Im, Young-Hyuck; Lee, Kyung Gee; Song, Hong-Suk; Lee, Myung-Ah; Lee, Junglim; Lee, Nam-Su; Ham, Hae Sun; Kim, Tae-You; Park, Yeon Hee; Lee, Kyung Eun; Kim, Kee Won; Seo, Jae Hong; Lee, Soon Nam; Hong, Young Seon; Bang, Yung-Jue; Kim, Woo-Kun; Park, Hee-Sook Oncology Reports, Vol.14 No.2, pp.481-487	DOI
2008-01	Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin Kim, Sun Young; Kim, Hwang Phill; Kim, Yu Jung; Oh, Do Youn; Im, Seock-Ah; Lee, Dongsoon; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue International Journal of Oncology, Vol.32 No.1, pp.89-95	DOI
2008-03	Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells Kim, Hwang-Phill; Han, Sae-Won; Kim, Sung-Hak; Im, Seock-Ah; Oh, Do-Youn; Bang, Yung-Jue; Kim, Tae-You Molecular Cancer Therapeutics, Vol.7 No.3, pp.607-615	DOI
2009-05	Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer Jung, So-Youn; Han, Wonshik; Lee, Jong Won; Ko, Eunyoung; Kim, Eunkyu; Yu, Jong-Han; Moon, Hyeong-Gon; Park, In Ae; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Hwang, Ki-Tae; Kim, Sung-Won; Noh, Dong-Young Annals of Surgical Oncology, Vol.16 No.5, pp.1112-1121	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-03	Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody Kim, Jun Gyu; Kang, Min Jueng; Yoon, Young-Kwang; Kim, Hwang-Phill; Park, Jinah; Song, Sang-Hyun; Han, Sae-Won; Park, Jong-Wan; Kang, Gyeong Hoon; Kang, Keon Wook; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Yi, Eugene C.; Kim, Tae-You PLoS ONE, Vol.7 No.3, p. e0033322	DOI

1